HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.

Abstract
To activate prodrugs for cancer treatment, an anti-TAG-72 antibody (HuCC49DeltaCH2) was used for delivery of an activation enzyme (beta-galactosidase) to specifically activate a geldanamycin prodrug (17-AG-C2-Gal) against colon cancer. The geldanamycin prodrug 17-AG-C2-Gal was synthesized by coupling a galactose-amine derivative with geldanamycin at the C-17 position. Molecular docking with two different programs (Affinity and Autodock) showed that the prodrug (17-AG-C2-Gal) was unable to bind to Hsp90; however, the product (17-AG-C2), enzymatically cleaved by beta-galactosidase conjugate, bound to Hsp90 in a similar way as geldanamycin and 17-AG. The computational docking results were further confirmed in experimental testing by the tetrazolium [3-(4,5-dimethythiazol-2-yl)]-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay and mass spectrometry. HuCC49DeltaCH2 was chemically conjugated to beta-galactosidase. The antibody-enzyme conjugate was able to target tumor antigen TAG-72 with the well-preserved enzymatic activity to activate 17-AG-C2-Gal prodrug. The released active drug 17-AG-C2 was demonstrated to induce up to 70% AKT degradation and enhance anticancer activity by more than 25-fold compared to the prodrug.
AuthorsLanyan Fang, Robert F Battisti, Hao Cheng, Philip Reigan, Yan Xin, Jie Shen, David Ross, Kenneth K Chan, Edward W Martin Jr, Peng George Wang, Duxin Sun
JournalJournal of medicinal chemistry (J Med Chem) Vol. 49 Issue 21 Pg. 6290-7 (Oct 19 2006) ISSN: 0022-2623 [Print] United States
PMID17034135 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 17-amino-17-demethoxygeldanamycin -C2-galactose
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Benzoquinones
  • Drug Carriers
  • Galactosides
  • Glycoproteins
  • HSP90 Heat-Shock Proteins
  • Indicators and Reagents
  • Lactams, Macrocyclic
  • Prodrugs
  • Tetrazolium Salts
  • Thiazoles
  • tumor-associated antigen 72
  • 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
  • Proto-Oncogene Proteins c-akt
  • beta-Galactosidase
  • 17-aminogeldanamycin
  • geldanamycin
Topics
  • Antibodies, Monoclonal (chemistry)
  • Antigens, Neoplasm (immunology)
  • Antineoplastic Agents (administration & dosage, chemistry, pharmacology)
  • Benzoquinones (chemistry)
  • Cell Line, Tumor
  • Colonic Neoplasms
  • Drug Carriers
  • Drug Delivery Systems
  • Galactosides (administration & dosage, chemistry)
  • Glycoproteins (immunology)
  • HSP90 Heat-Shock Proteins (chemistry, metabolism)
  • Humans
  • Indicators and Reagents
  • Lactams, Macrocyclic (administration & dosage, chemistry)
  • Mass Spectrometry
  • Models, Molecular
  • Prodrugs (administration & dosage, chemistry, pharmacology)
  • Protein Binding
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Tetrazolium Salts
  • Thiazoles
  • beta-Galactosidase (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: